by David Wallace What are some of the latest combination drug treatments in development for MPN?  Find out the latest on combination add-on strategies to JAK inhibitors and other new agents.  Two combination therapies for Myelofibrosis look promising as they move into phase 3 clinical trials.  They include adding CPI-0610 (a bromodomain, BET, inhibitor) and […]